LifeMD, Inc. (LFMD)
NASDAQ: LFMD · IEX Real-Time Price · USD
11.95
+1.13 (10.44%)
At close: Apr 26, 2024, 4:00 PM
12.00
+0.05 (0.42%)
After-hours: Apr 26, 2024, 7:31 PM EDT
LifeMD Revenue
In the year 2023, LifeMD had annual revenue of $152.55M with 28.15% growth. Revenue in the quarter ending December 31, 2023 was $44.86M with 59.53% year-over-year growth.
Revenue (ttm)
$152.55M
Revenue Growth
+28.15%
P/S Ratio
3.16
Revenue / Employee
$736,942
Employees
207
Market Cap
482.37M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | 12.47M | 4.14M | 49.79% |
Dec 31, 2018 | 8.32M | 4.64M | 126.09% |
Dec 31, 2017 | 3.68M | -1.56M | -29.72% |
Dec 31, 2016 | 5.24M | 4.02M | 329.79% |
Dec 31, 2015 | 1.22M | 504.70K | 70.67% |
Dec 31, 2014 | 714.16K | -94.21K | -11.65% |
Dec 31, 2013 | 808.36K | 134.59K | 19.97% |
Dec 31, 2012 | 673.78K | -70.05K | -9.42% |
Dec 31, 2011 | 743.83K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aveanna Healthcare Holdings | 1.90B |
Nevro | 425.17M |
Editas Medicine | 78.12M |
Theravance Biopharma | 57.42M |
C4 Therapeutics | 20.76M |
Fulcrum Therapeutics | 2.81M |
LFMD News
- 3 days ago - LifeMD to Report First Quarter 2024 Financial Results on May 8 - GlobeNewsWire
- 4 weeks ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 4 weeks ago - LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - LifeMD Reports Fourth Quarter 2023 Results - GlobeNewsWire
- 3 months ago - LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 3 months ago - LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference - GlobeNewsWire
- 4 months ago - LifeMD Stock Pops on Medifast Agreement. It's All About Weight-Loss Drugs. - Barrons
- 4 months ago - LifeMD's stock soars 9.5% on news company is teaming up with Medifast to create weight-management program that includes GLP-1 drugs - Market Watch